A multicenter dosimetry trial to evaluate radiation absorbed dose from holmium-166-DOTMP in patients with multiple myeloma

Trial Profile

A multicenter dosimetry trial to evaluate radiation absorbed dose from holmium-166-DOTMP in patients with multiple myeloma

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Apr 2009

At a glance

  • Drugs Holmium-166-DOTMP; Melphalan
  • Indications Multiple myeloma
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top